Biliary Tract Cancer
📧 Sign up to get email alerts when something new happens for Biliary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: Tislelizumab（Anti PD-1), Lenvatinib and GEMOX Transformation in the Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial update investigating tislelizumab with lenvatinib and GEMOX for potentially resectable, locally advanced biliary trac…
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of CAN04 in combination with various chemotherapy regimens for advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer [Phase 2]
A Phase 2 trial evaluated atezolizumab with or without bevacizumab in combination with cisplatin and gemcitabine for untreated, advanced bil…
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Oncolytic Virotherapy Combined With Tislelizumab Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer (OPTIONS-05) [Phase 2]
Phase 2 clinical trial exploring a combination of oncolytic virotherapy with tislelizumab and lenvatinib in advanced biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-23Clinical Trial Update: HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC [Phase 2]
A Phase 2 trial evaluating hepatic arterial infusion chemotherapy with oxaliplatin, 5-fluorouracil, and bevacizumab in combination with intr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer [Phase 3]
Phase 3 trial comparing NUC-1031 plus cisplatin versus gemcitabine plus cisplatin in advanced biliary tract cancer was terminated with resul…
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer [Phase 2]
Phase 2 trial update for XERMELO in combination with first-line chemotherapy in advanced biliary tract cancer; the study is terminated with …
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1) [Phase 3]
Phase 3 TOPAZ-1 trial results for durvalumab in combination with gemcitabine/cisplatin in first-line biliary tract cancer have been posted.
-
CLINICAL_TRIALS trial_result · 2023-04-03Clinical Trial Update: IBI310 in Combination With Sintilimab in Patients With Advanced Biliary Tract Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating IBI310 in combination with sintilimab for advanced biliary tract cancer is ongoing; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers [Phase 2]
Phase 2 trial update evaluating toripalimab plus lenvatinib as second-line treatment for advanced biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08） [Phase 2]
Phase 2 trial evaluating cryoablation with sintilimab and lenvatinib in patients with advanced biliary tract cancer who have previously rece…
-
FDA approval · 2023-03-07FDA Approved: GEMCITABINE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s generic gemcitabine under an Original Application (ANDA). This marks the approval of a generic…
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors [Phase 1, Phase 2]
A Phase I/II study investigating regorafenib in combination with avelumab in various solid tumors, spanning Phase 1 and Phase 2 cohorts.
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer [Phase 1, Phase 2]
Phase Ib/II clinical trial evaluating camrelizumab and apatinib plus GP in locally advanced or metastatic biliary tract cancer; status is un…
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract Cancer [Phase 2]
Phase 2 trial investigating a Gemcitabine, Oxaliplatin, Sintilimab, and Bevacizumab combination in unresectable biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2022-12-07Clinical Trial Update: Durvalumab Combined With Chemotherapy Neoadjuvant Therapy of Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial update on durvalumab combined with neoadjuvant chemotherapy for resectable biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma [Phase 2]
A Phase 2 trial comparing adjuvant capecitabine to a gemcitabine plus cisplatin regimen in resected extrahepatic cholangiocarcinoma has comp…
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN) [Phase 2]
Phase 2 trial evaluating Envofolimab and Lenvatinib with Gemcitabine plus Cisplatin as first-line therapy for advanced biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Study of SMT-NK Inj. Plus Pembrolizumab vs Pembrolizumab Monotherapy in Patients With Advanced Biliary Tract Cancer [Phase 2, Phase 3]
A study comparing SMT-NK Inj. plus pembrolizumab versus pembrolizumab alone in advanced biliary tract cancer is currently recruiting (Phase …
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: Lenvatinib Combined With PD-1 Inhibitors as First-line Treatment for Unresectable/Advanced Biliary Tract Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating lenvatinib plus PD-1 inhibitors as first-line therapy for unresectable or advanced biliary tract cancer …
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Tislelizumab+Lenvatinib+Gemox Regiment for Potentially Resectable Locally Advanced Malignant Tumors of Biliary System. [Phase 2]
Phase 2 trial investigating tislelizumab plus lenvatinib and gemox for potentially resectable locally advanced malignant tumors of the bilia…
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid Tumors [Phase 2]
Phase 2 trial evaluating surufatinib combined with sintilimab and SCRT in various unresectable advanced solid tumors, including biliary trac…
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial of nal-IRI plus 5-FU/LV in metastatic biliary tract cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies [Phase 2, Phase 3]
A trial update evaluating chemotherapy combined with immune checkpoint inhibitors in advanced biliary tract cancers across Phase 2 and Phase…
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Study of Pembrolizumab in Metastatic Biliary Tract Cancer as Second-line Treatment After Failing to at Least One Cytotoxic Chemotherapy Regimen: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes [Phase 2]
Phase 2 trial evaluating pembrolizumab as second-line treatment for metastatic biliary tract cancer with integrated genomic analysis to iden…